Market Cap | 86.96M | P/E | 88.50 | EPS this Y | - | Ern Qtrly Grth | - |
Income | -242.74k | Forward P/E | - | EPS next Y | - | 50D Avg Chg | - |
Sales | - | PEG | - | EPS past 5Y | - | 200D Avg Chg | 3.00% |
Dividend | N/A | Price/Book | N/A | EPS next 5Y | - | 52W High Chg | -8.00% |
Recommedations | - | Quick Ratio | 0.03 | Shares Outstanding | 6.01M | 52W Low Chg | 7.00% |
Insider Own | 47.86% | ROA | -2.62% | Shares Float | 1.15M | Beta | 0.01 |
Inst Own | 41.04% | ROE | - | Shares Shorted/Prior | 7.51K/44 | Price | 10.62 |
Gross Margin | - | Profit Margin | - | Avg. Volume | 18,361 | Target Price | - |
Oper. Margin | - | Earnings Date | - | Volume | 75,102 | Change | 0.00% |
Globalink Investment Inc. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to identify and acquire businesses in the medical technology and green energy sectors in North America, Europe, Southeast Asia, and Asia excluding China, Hong Kong, and Macau. Globalink Investment Inc. was incorporated in 2021 and is based in Newark, Delaware.